City

Atlanta (1)

Baltimore (1)

Bethesda (1)

Boston (1)

Overland Park (1)

Syracuse (1)

Condition

Pseudomonas Infection (4)

Cystic Fibrosis (1)

Fever (1)

Gram-positive Bacterial Infections (1)

Neutropenia (1)

Overall Status

Completed (3)

Terminated (1)

Sign in for free

Phase

phase 1 (2)

phase 3 (1)

Sponsor

Basilea Pharmaceutica (1)

Bayer (1)

National Heart, Lung, and Blood Institute (NHLBI) (1)

National Institute of Allergy and Infectious Diseases (NIAID) (1)

Collaborator

Intervention

cefepime with or without vancomycin (1)

ceftobiprole medocaril (1)

ciprofloxacin (cipro, bayq3939) (1)

fosfomycin disodium (1)

fosfomycin tromethamine (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (2)

NIH (2)

Study Type

Interventional (3)

Observational (1)

pseudomonas infection

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Toxins in Lung Infections Caused by Pseudomonas Aeruginosa

Completed

Pseudomonas Infection
Cystic Fibrosis

Bethesda, Maryland

National Institutes of Health Clinical Center, 9000 Rockville Pi

Jun 3, 2022

Pseudomonas Infection Trial in Overland Park (Fosfomycin tromethamine, Fosfomycin disodium)

Completed

Pseudomonas Infection

Fosfomycin tromethamine
Fosfomycin disodium

Overland Park, Kansas

Quintiles Phase I Services - Overland Park

Mar 31, 2016

Pseudomonas Infection Trial in United States (Ciprofloxacin (Cipro, BAYQ3939))

Completed

Pseudomonas Infection

Ciprofloxacin (Cipro, BAYQ3939)

Atlanta, Georgia
+3 more

Nov 20, 2013

Fever, Neutropenia, Gram-positive Bacterial Infections Trial (Ceftobiprole Medocaril, Cefepime with or without vancomycin)

Terminated

Fever
+3 more

Ceftobiprole Medocaril
Cefepime with or without vancomycin

(no location specified)

Jul 26, 2012